Return on Innovation, Part 6: Clinical Trial Sites

GettyImages-998296772

Harris-Williams Bio-Crop 0067 1421 PaulHepper

Managing Director

Profile

Harris-Williams Bio-Crop 0009 0181 CheairsPorter

Harris-Williams Bio-Crop 0074 1198 GeoffSmith

Harris Williams advised Cerberus on its acquisition of a Clinical Trial Site Management Platform.

Clinical Trial Site Management Platform

United States

5569_artc_project_atlantic_cerberus.png

Mergers & Acquisitions

Harris Williams advised Velocity Clinical Research (Velocity), a portfolio company of NaviMed Capital, on its sale to Global Healthcare Opportunities, or GHO Capital Partners LLP. Velocity is a leading integrated site organization for clinical trials.

Velocity Clinical Research

5203-velocity-clinical-research.png

A leading independent clinical research site services company. 
 
 A portfolio company of DFW Capital Partners 
 
 Has been acquired by Linden Capital Partners, Chicago, Illinois

Evolution Research Group, LLC

evolution-research-group.gif

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Careers

Contact Us

Experienced Bankers

Analysts

Associates

Search for People, Insights, Transactions...

M&A Drivers

Full Report

Clinical Trial Sites Overview Q1 2023 4.8.24 update

Featured Engagements

Return on Innovation: An Eight-Part Series

Featured Engagements

Related Insights

Return on Innovation: An Eight-Part Series